Updated
Reviewed
Jan. 17, 2020
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Table 8. Antiretroviral Drug Use in Pregnant Women with HIV Infection: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy
Note: When using FDCs, refer to other sections in Appendix B and Table 8 for information about the dosing and safety of individual drug components of the FDC during pregnancy.
| Table 8. Antiretroviral Drug Use in Pregnant Women with HIV Infection: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | |
|---|---|
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Table 8. Antiretroviral Drug Use in Pregnant Women with HIV Infection: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy
Note: When using FDCs, refer to other sections in Appendix B and Table 8 for information about the dosing and safety of individual drug components of the FDC during pregnancy.
| Table 8. Antiretroviral Drug Use in Pregnant Women with HIV Infection: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | |
|---|---|
Documents
Section OnlyPDF (310.89 KB)
Full GuidelinePDF (2.76 MB)
Recommendations OnlyPDF (313.35 KB)
Tables OnlyPDF (572.94 KB)
Download Guidelines
- Section OnlyPDF (310.89 KB)
- Full GuidelinePDF (2.76 MB)
- Recommendations OnlyPDF (313.35 KB)
- Tables OnlyPDF (572.94 KB)